In the present study, we showed that ZFX was highly expressed in CD34+ cells from CML patients in both chronic phase and blast crisis; moreover, ZFX expression was higher in blast crisis patients than in chronic phase patients. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.